Position in RVMD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$85,461,669
+$44,088,505 QoQ
Shares Held
456,331
+7.3% QoQ
Ownership
0.213%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#69
of 687 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. RVMD ranks #4 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
717,440 | $356,373,971 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
293,020 | $182,709,690 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
374,080 | $112,609,302 | |
| 4 | RVMD |
Revolution Medicines, Inc.
This page
|
456,331 | $85,461,669 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,159,800 | $65,029,986 | |
| 6 | INSM |
INSMED Inc
|
593,512 | $63,280,249 | |
| 7 | INCY |
Incyte Corp
|
476,874 | $54,058,436 | |
| 8 | MRNA |
Moderna, Inc.
|
679,900 | $47,613,397 |
All Filings in RVMD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,461,669 | 456,331 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $41,373,164 | 425,431 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $22,009,764 | 276,331 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,647,807 | 270,831 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,801,996 | 266,431 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $9,778,136 | 276,531 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $10,057,181 | 229,931 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $10,227,830 | 225,531 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $8,803,311 | 226,831 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $6,450,222 | 200,131 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $5,739,757 | 200,131 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,528,448 | 163,600 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,328,150 | 161,800 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,651,876 | 168,600 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $3,532,506 | 148,300 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,806,156 | 142,300 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,030,858 | 104,200 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,887,732 | 113,200 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,655,435 | 105,500 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,902,305 | 105,500 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $3,281,916 | 103,400 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,087,540 | 45,500 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,769,673 | 44,700 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $1,259,760 | 36,200 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $830,291 | 26,300 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||